loadpatents
name:-0.22210192680359
name:-0.05759596824646
name:-0.016928911209106
Lixte Biotechnology, Inc. Patent Filings

Lixte Biotechnology, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lixte Biotechnology, Inc..The latest application filed is for "oxabicycloheptane prodrugs".

Company Profile
16.38.40
  • Lixte Biotechnology, Inc. - Pasadena CA US
  • Lixte Biotechnology, Inc. - East Setauket NY US
  • Lixte Biotechnology, Inc. - Setauket NY
  • Lixte Biotechnology, Inc. -
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Oxabicycloheptane Prodrugs
App 20220235066 - KOVACH; John S. ;   et al.
2022-07-28
Clinical Regimen For Treating Myelodysplastic Syndrome With Phosphatase Inhibitor
App 20220184066 - LIST; ALAN F. ;   et al.
2022-06-16
Oxabicycloheptane prodrugs
Grant 11,236,102 - Kovach , et al. February 1, 2
2022-02-01
Oxabicycloheptanes For Enhancing Car T Cell Function
App 20210379106 - KOVACH; John S. ;   et al.
2021-12-09
Oxabicycloheptanes For Treatment Of Secondary Acute Myeloid Leukemia
App 20210275521 - KOVACH; John S.
2021-09-09
Oxabicycloheptane Prodrugs
App 20200325151 - KOVACH; John S. ;   et al.
2020-10-15
Formulations Of Oxabicycloheptanes And Oxabicycloheptenes
App 20200179375 - Kovach; John S. ;   et al.
2020-06-11
Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes
Grant 10,668,062 - Kovach
2020-06-02
Oxabicycloheptane prodrugs
Grant 10,618,908 - Kovach , et al.
2020-04-14
Oxabicycloheptanes For Modulation Of Immune Response
App 20200069680 - Kovach; John S. ;   et al.
2020-03-05
Formulations of oxabicycloheptanes and oxabicycloheptenes
Grant 10,532,050 - Kovach , et al. Ja
2020-01-14
Oxabicycloheptane Prodrugs
App 20190359627 - Kovach; John S. ;   et al.
2019-11-28
Protein phosphatase 2A inhibitors for treating myelodysplastic syndromes
Grant 10,434,100 - List , et al. O
2019-10-08
Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders
Grant 10,413,541 - Kovach , et al. Sept
2019-09-17
Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
Grant 10,399,993 - Kovach , et al. Sep
2019-09-03
Oxabicycloheptane prodrugs
Grant 10,364,252 - Kovach , et al.
2019-07-30
Oxabicycloheptanes And Oxabicycloheptenes For The Treatment Of Diabetes
App 20190167671 - Kovach; John S.
2019-06-06
Clinical Regimen For Treating Myelodysplastic Syndrome With Phosphatase Inhibitor
App 20190111053 - List; Alan F. ;   et al.
2019-04-18
Protein Phosphatase 2a Inhibitors For Treating Myelodysplastic Syndromes
App 20190046525 - List; Alan F. ;   et al.
2019-02-14
Oxabicycloheptanes And Oxabicycloheptenes, Their Preparation And Use
App 20180370983 - KOVACH; John S. ;   et al.
2018-12-27
Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes
Grant 10,149,847 - Kovach Dec
2018-12-11
Oxabicycloheptanes And Oxabicycloheptenes For The Treatment Of Depressive And Stress Disorders
App 20180256565 - Kovach; John S. ;   et al.
2018-09-13
Protein phosphatase 2A inhibitors for treating myelodysplastic syndromes
Grant 10,071,094 - List , et al. September 11, 2
2018-09-11
Oxabicycloheptane Prodrugs
App 20180244690 - Kovach; John S. ;   et al.
2018-08-30
Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
Grant 10,023,587 - Kovach , et al. July 17, 2
2018-07-17
Process of synthesizing 3-(4-methylpiperazine-1-carbonyl)-7-oxabicyclo[2.2.1] heptane-2-carboxylic acid
Grant 9,994,584 - Piotrowski , et al. June 12, 2
2018-06-12
Oxabicycloheptane prodrugs
Grant 9,988,394 - Kovach , et al. June 5, 2
2018-06-05
Oxabicycloheptanes And Oxabicycloheptenes, Their Preparation And Use
App 20170369503 - KOVACH; John S ;   et al.
2017-12-28
Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders
Grant 9,833,450 - Kovach , et al. December 5, 2
2017-12-05
Protein Phosphatase 2a Inhibitors For Treating Myelodysplastic Syndromes
App 20170340628 - List; Alan F. ;   et al.
2017-11-30
Process Of Synthesizing 3-(4-methylpiperazine-1-carbonyl)-7-oxabicyclo[2.2.1] Heptane-2-carboxylic Acid
App 20170305925 - Piotrowski; Jason J. ;   et al.
2017-10-26
Methods For Regulating Cell Mitosis By Inhibiting Serine/threonine Phosphatase
App 20170259081 - Kovach; John S.
2017-09-14
Sanguinarine Analog Pp2c Inhibitors For Cancer Treatment
App 20170240558 - KOVACH; John S. ;   et al.
2017-08-24
Oxabicycloheptanes And Oxabicycloheptenes For The Treatment Of Ovarian Cancer
App 20170136008 - Kovach; John S. ;   et al.
2017-05-18
Oxabicycloheptane Prodrugs
App 20160333024 - KOVACH; JOHN S. ;   et al.
2016-11-17
Oxabicycloheptanes And Oxabicycloheptenes For The Treatment Of Depressive And Stress Disorders
App 20160303115 - KOVACH; JOHN S. ;   et al.
2016-10-20
Human Dosing Of Phosphatase Inhibitor
App 20160074390 - KOVACH; JOHN S.
2016-03-17
Formulations Of Oxabicycloheptanes And Oxabicycloheptenes
App 20160051544 - KOVACH; John S. ;   et al.
2016-02-25
Sanguinarine Analog Pp2c Inhibitors For Cancer Treatment
App 20160009727 - KOVACH; John S. ;   et al.
2016-01-14
Hdac Inhibitors For The Treatment Of Traumatic Brain Injury
App 20160008336 - KOVACH; John S.
2016-01-14
Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
Grant 9,079,917 - Kovach , et al. July 14, 2
2015-07-14
Oxabicycloheptanes And Oxabicycloheptenes For The Treatment Of Reperfusion Injury
App 20150174123 - Kovach; John S.
2015-06-25
Oxabicycloheptanes And Oxabicycloheptenes For The Treatment Of Diabetes
App 20150148353 - Kovach; John S.
2015-05-28
Oxabicycloheptanes And Oxabicycloheptenes, Their Preparation And Use
App 20150045373 - KOVACH; John S. ;   et al.
2015-02-12
Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
Grant 8,822,461 - Kovach , et al. September 2, 2
2014-09-02
Use Of Phosphatase Inhibitors Or Histone Deacetylase Inhibitors To Treat Diseases Characterized By Loss Of Protein Function
App 20140235649 - Kovach; John S. ;   et al.
2014-08-21
Oxabicycloheptanes And Oxabicycloheptenes, Their Preparation And Use
App 20130302402 - KOVACH; John S. ;   et al.
2013-11-14
Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
Grant 8,541,458 - Kovach , et al. September 24, 2
2013-09-24
HDAC inhibitors
Grant 8,455,688 - Kovach , et al. June 4, 2
2013-06-04
Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
Grant 8,426,444 - Kovach , et al. April 23, 2
2013-04-23
Neuroprotective agents for the prevention and treatment of neurodegenerative diseases
Grant 8,329,719 - Kovach December 11, 2
2012-12-11
Oxabicycloheptanes And Oxabicycloheptenes, Their Preparation And Use
App 20120270736 - Kovach; John S. ;   et al.
2012-10-25
Oxabicycloheptanes and Oxabicycloheptenes, Their Preparation and Use
App 20120264764 - Kovach; John S. ;   et al.
2012-10-18
Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
Grant 8,227,473 - Kovach , et al. July 24, 2
2012-07-24
Hdac Inhibitors
App 20120178783 - Kovach; John S. ;   et al.
2012-07-12
HDAC inhibitors
Grant 8,143,445 - Kovach , et al. March 27, 2
2012-03-27
Neuroprotective Agents For The Prevention And Treatment Of Neurodegenerative Diseases
App 20110287537 - Kovach; John S.
2011-11-24
Neuroprotective agents for the prevention and treatment of neurodegenerative diseases
Grant 8,058,268 - Kovach November 15, 2
2011-11-15
Oxabicycloheptanes and oxabicylcoheptenes, their preparation and use
Grant 7,998,957 - Kovach , et al. August 16, 2
2011-08-16
Neuroprotective agents for the prevention and treatment of neurodegenerative diseases
App 20100029640 - Kovach; John S.
2010-02-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed